Sign up to save your podcasts
Or
Share Understanding Blood-Based Biomarkers in Alzheimer Disease
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Understanding Blood-Based Biomarkers in Alzheimer Disease
Dr. Dan Ackerman talks with Dr. Trey Bateman about the significance of blood-based biomarkers in Alzheimer disease.
Purchase Annual Meeting On Demand to get access to the recordings and the ability to claim CME through March 1, 2026.
Disclosures can be found at Neurology.org.
View all episodes
By American Academy of Neurology
4.7
284284 ratings
Dr. Dan Ackerman talks with Dr. Trey Bateman about the significance of blood-based biomarkers in Alzheimer disease.
Purchase Annual Meeting On Demand to get access to the recordings and the ability to claim CME through March 1, 2026.
Disclosures can be found at Neurology.org.
More shows like Neurology® Podcast
View all
NEJM This Week
323 Listeners
JAMA Clinical Reviews
498 Listeners
Practical Neurology Podcast
46 Listeners
Mayo Clinic Talks
294 Listeners
The Curbsiders Internal Medicine Podcast
3,361 Listeners
JAMA Neurology Author Interviews
13 Listeners
Core IM | Internal Medicine Podcast
1,145 Listeners
Neurology Today in 5
24 Listeners
Annals On Call Podcast
191 Listeners
The Clinical Problem Solvers
515 Listeners
Neurology Minute
137 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
369 Listeners
Neurology Exam Prep Podcast
190 Listeners
The Curious Clinicians
375 Listeners
Continuum Audio
83 Listeners